BioNexus Gene Lab Corp. Proceeds from Income Tax Refunds
BioNexus Gene Lab Corp. (BGLC) reported Proceeds from Income Tax Refunds of $312 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2024-04-16
- BioNexus Gene Lab Corp. proceeds from income tax refunds for the quarter ending 2023-12-31 was -$3.00.
- BioNexus Gene Lab Corp. proceeds from income tax refunds for the quarter ending 2022-12-31 was $0.00.
- BioNexus Gene Lab Corp. proceeds from income tax refunds for fiscal 2023 was $312.00.
- BioNexus Gene Lab Corp. proceeds from income tax refunds for fiscal 2022 was $0.00.
| Period end | Proceeds from Income Tax Refunds 3 month | Proceeds from Income Tax Refunds 9 month | Proceeds from Income Tax Refunds 12 month |
|---|---|---|---|
| 2023-12-31 | -$3.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $312.00 10-K · filed 2024-04-16 | |
| 2023-09-30 | $315.00 10-Q/A · filed 2024-03-26 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 | |
| 2022-09-30 | $0.00 10-Q/A · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |